A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

Osteoarthritis Pain of the Knee Clinical Trial

Official title: A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee

Status Not yet recruiting

Clinical Trial Summary

A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee

Clinical Trial Description

This is a multi-center, randomized, double-blind, and placebo-controlled phase 3 study evaluating the safety and efficacy of HP-5000 in subjects with OA pain of the knees. The study will consist of up to a 28-day Screening Phase that will include a Washout Period of current prescription and over the counter (OTC) analgesics; a 12-week Double-blind Treatment Phase, and a 1-week safety Follow-up Phase. ;

Related Conditions & MeSH terms

• Osteoarthritis
• Osteoarthritis Pain of the Knee

• NCT number: NCT04640675
• Study type: Interventional
• Source: Noven Therapeutics
• Contact: HP-5000 Project Team
• Phone: (551) 233-2656
• Email: HP5000@noven.com
• Status: Not yet recruiting
• Phase: Phase 3
• Start date: December 2020
• Completion date: December 2022